Stock search

Ticker or company name

MRNA card

MRNA price forecast

Moderna$215,27

Average over 5 years: 13,4 (range 5–12).

Base · FY2030

n/a (loss)

The base case has a loss: P/E cannot price it.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$3,89 bn$7,80 bn$15,6 bn$31,3 bn$62,8 bn
Net income−$1,67 bn−$3,35 bn−$6,71 bn−$13,4 bn−$26,9 bn
EPS−$4,16−$8,07−$15,66−$30,37−$58,92

Changed values are highlighted. Bear and bull cases: growth ∓ 13692,1%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $215,27

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$429 595 817 390,27

Price change
+199 561 396 002,7%
A year
+17 995,4%
Fair value today
$290 096 435 001,94
Margin of safety
+134 759 341 657,8%

Basen/a (loss)

Bulln/a (loss)

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030n/a (loss)